Hospitalist, Internists, Critical Care Specialist, Obstetrician & Gynecologist (OB/GYN)
25 years of experience

Accepting new patients
Texas Health Care
2821 Lackland Rd
Ste 216
Fort Worth, TX 76116
Locations and availability (4)

Education ?

Medical School Score
The University of Texas Southwestern (1985)
  • Currently 1 of 4 apples

Awards & Distinctions ?

Castle Connolly Top Doctors: Texas™ (2009)

Affiliations ?

Dr. Martinez is affiliated with 11 hospitals.

Hospital Affilations



  • Baylor All Saints Medical Centers
    1400 8th Ave, Fort Worth, TX 76104
    • Currently 4 of 4 crosses
    Top 25%
  • Texas Health Harris Methodist Hospital Fort Worth
    1301 Pennsylvania Ave, Fort Worth, TX 76104
    • Currently 4 of 4 crosses
    Top 25%
  • Texas Health Harris Methodist Hospital Southwest Fort Worth
    6100 Harris Pkwy, Fort Worth, TX 76132
    • Currently 4 of 4 crosses
    Top 25%
  • Harris Methodist H E B
    1600 Hospital Pkwy, Bedford, TX 76022
    • Currently 4 of 4 crosses
    Top 25%
  • Texas Health Harris Methodist Hospital Azle
    108 Denver Trl, Azle, TX 76020
    • Currently 3 of 4 crosses
    Top 50%
  • Texas Health Presbyterian Hospital Of Dallas
    8200 Walnut Hill Ln, Dallas, TX 75231
    • Currently 3 of 4 crosses
    Top 50%
  • Harris Continued Care Hospital
    1301 Pennsylvania Ave, Fort Worth, TX 76104
  • Texas Health Fort Worth
  • Harris Methodist - Springwood
    1608 Hospital Pkwy, Bedford, TX 76022
  • Lifecare
  • Baylor All Saints
  • Publications & Research

    Dr. Martinez has contributed to 2 publications.
    Title Intralesional Administration of Epidermal Growth Factor-based Formulation (heberprot-p) in Chronic Diabetic Foot Ulcer: Treatment Up to Complete Wound Closure.
    Date July 2009
    Journal International Wound Journal

    Previous studies have shown that an epidermal growth factor-based formulation (Heberprot-P) can enhance granulation of high-grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to complete wound closure. A pilot study in 20 diabetic patients with full-thickness lower extremity ulcers of more than 4 weeks of evolution was performed. Mean ulcer size was 16.3 +/- 21.3 cm(2). Intralesional injections of 75 microg of Heberprot-P three times per week were given up to complete wound healing. Full granulation response was achieved in all 20 patients in 23.6 +/- 3.8 days. Complete wound closure was obtained in 17 (85%) cases in 44.3 +/- 8.9 days. Amputation was not necessary in any case and only one relapse was notified. The most frequent adverse events were tremors, chills, pain and odour at site of administration and local infection. The therapeutic scheme of intralesional Heberprot-P administration up to complete closure can be safe and suitable to improve the therapeutic goal in terms of healing of chronic DFU.

    Title Developing Country Vaccine Manufacturers Network (dcvmn), 26-27 April 2001, Bandung, Indonesia.
    Date January 2002
    Journal Vaccine

    Similar doctors nearby

    Dr. Alexander Peralta

    31 years experience
    Duncanville, TX

    Dr. Kanthi Yalamanchili

    Internal Medicine
    9 years experience
    Southlake, TX

    Dr. Russell Fisher

    Internal Medicine
    32 years experience
    Bedford, TX

    Dr. Salman Ahmad

    21 years experience
    Flower Mound, TX

    Dr. Dan Waddell

    Internal Medicine
    40 years experience
    Hurst, TX

    Dr. Michael McInnis

    General Practice
    10 years experience
    Arlington, TX
    Search All Similar Doctors